Cardiovascular Morbidity in COPD: A Study of the General Population
about
Combined effect of lung function level and decline increases morbidity and mortality risksLung Function, Percent Emphysema, and QT Duration: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung StudyIschemic heart disease among subjects with and without chronic obstructive pulmonary disease--ECG-findings in a population-based cohort study.Heart failure and levels of other comorbidities in patients with chronic obstructive pulmonary disease in a Swedish population: a register-based studyElevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007-2010.INDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology units.Rationale for earlier treatment in COPD: a systematic review of published literature in mild-to-moderate COPD.Comorbidity of heart failure and chronic obstructive pulmonary disease: more than coincidence.Ischemic ECG abnormalities are associated with an increased risk for death among subjects with COPD, also among those without known heart disease.Airway obstruction and the risk of myocardial infarction and death from coronary heart disease: a national health examination survey with a 33-year follow-up period.Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care.Socioeconomic status and prognosis of COPD in Denmark.The Evaluation of Interstitial Abnormalities in Group B of the 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Classification of Chronic Obstructive Pulmonary Disease (COPD).Changes in definition lead to changes in the clinical characteristics across COPD categories according to GOLD 2017: a national cross-sectional survey in China.Defining the relationship between COPD and CVD: what are the implications for clinical practice?Prediction of the Clinical Course of Chronic Obstructive Pulmonary Disease, Using the New GOLD Classification
P2860
Q23919385-CF55F3A9-71A8-4C0E-B55C-2CEB3651EF51Q29248734-0F47DD0F-56B5-4E7E-A766-1E1EE9E45B3EQ35861330-47EC76A1-AD2D-4F2B-A791-C6EFEE710C48Q35986343-84BF8309-8463-4B9D-8C49-D59B52B2281AQ36539136-F56563EA-070C-4985-A58D-EEE76B5CB2FDQ36797618-87D68194-D64B-4B34-9E88-8BACFEEE1954Q38070173-9B591E2E-0743-425D-90F1-A10ED4823C49Q38224810-A9DA7831-1728-41C7-8FCA-681C2D4EC0EEQ38598984-521B9703-3D6E-4692-ADB9-F962F29ED143Q38688695-1B5E1886-396F-493A-A58C-173F090E17F5Q38944856-B904B5DA-2261-45A4-997D-B648469E36B9Q40173426-556F7E16-22B7-4AE6-9797-6A3EF05E007FQ44465190-4B3E1B7A-DE2D-42AF-A7A9-3C67ED57AEB9Q47150225-53D43BDF-2550-430B-848F-E0E9972242B4Q47651592-DC7197CC-1816-4F72-8D03-574C7945A545Q57955707-7550785F-2F2F-490C-8E5A-645E3B366413
P2860
Cardiovascular Morbidity in COPD: A Study of the General Population
description
im März 2010 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2010
@uk
name
Cardiovascular Morbidity in COPD: A Study of the General Population
@en
Cardiovascular Morbidity in COPD: A Study of the General Population
@nl
type
label
Cardiovascular Morbidity in COPD: A Study of the General Population
@en
Cardiovascular Morbidity in COPD: A Study of the General Population
@nl
prefLabel
Cardiovascular Morbidity in COPD: A Study of the General Population
@en
Cardiovascular Morbidity in COPD: A Study of the General Population
@nl
P2093
P2860
P1476
Cardiovascular Morbidity in COPD: A Study of the General Population
@en
P2093
Jacob Louis Marott
Jan Skov Jensen
Peter Lange
Rasmus Mogelvang
P2860
P356
10.3109/15412550903499506
P407
P577
2010-03-09T00:00:00Z